Absorbed Doses to All Organs for Different Treatment Regimens
| Organ | With lilotomab predosing | Without lilotomab predosing |
| Adrenals | 0.12 (0.10–0.14) | 0.09 (0.07–0.12) |
| Brain | 0.10 (0.08–0.13) | 0.07 (0.05–0.10) |
| Breasts | 0.10 (0.08–0.12) | 0.07 (0.05–0.10) |
| Gallbladder wall | 0.12 (0.10–0.14) | 0.09 (0.07–0.12) |
| Lower large intestine wall | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| Small intestine | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| Stomach wall | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| Upper large intestine wall | 0.11 (0.09–0.14) | 0.08 (0.06–0.11) |
| Heart wall | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| Kidneys | 0.46 (0.28–0.79) | 0.27 (0.16–0.30) |
| Liver | 0.97 (0.74–1.15) | 0.89 (0.70–1.05) |
| Lungs | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| Muscle | 0.10 (0.08–0.13) | 0.08 (0.06–0.10) |
| Ovaries | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| Pancreas | 0.12 (0.10–0.14) | 0.1 (0.07–0.12) |
| Osteogenic cells | 0.50 (0.31–0.70) | 0.81 (0.63–1.03) |
| Red marrow | 0.91 (0.63–1.18) | 1.51 (1.39–1.78) |
| Skin | 0.10 (0.08–0.12) | 0.07 (0.05–0.09) |
| Spleen | 2.81 (1.54–3.60) | 3.01 (2.65–3.45) |
| Testes | 0.10 (0.08–0.13) | 0.07 (0.05–0.10) |
| Thymus | 0.11 (0.09–0.13) | 0.08 (0.06–0.10) |
| Thyroid | 0.10 (0.08–0.13) | 0.07 (0.05–0.10) |
| Urinary bladder wall | 0.11 (0.09–0.13) | 0.08 (0.06–0.10) |
| Uterus | 0.11 (0.09–0.13) | 0.08 (0.06–0.11) |
| WB | 0.14 (0.12–0.17) | 0.12 (0.08–0.15) |
Data are mean mGy/MBq, followed by range in parentheses.